ChemicalBook >
제품 카탈로그 >2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate
2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate
2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate 구조식 이미지
카스 번호:
1367369-78-5
상품명:
2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate
동의어(영문):
(1R,3R,4S);Cave Impurity B;1'-epi-Entecavir;Entecavir impurity A -F;Entecavir EP Impurity A;Entecavir 1-epimer impurity;Entecavir (1R,3R,4S) Diastereomer;Entecavir non corresponding isomer 1;Entecavir EP Impurity A (1'-epi-Entecavir);Entecavir Impurity 6(Entecavir EP Impurity A)
CBNumber:
CB63050734
분자식:
C12H15N5O3
포뮬러 무게:
277.28
MOL 파일:
1367369-78-5.mol
2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate 속성
끓는 점
661.4±65.0 °C(Predicted)
밀도
1.81±0.1 g/cm3(Predicted)
산도 계수 (pKa)
14.22±0.60(Predicted)
안전
2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate C화학적 특성, 용도, 생산
용도
An epimeric impurity of the antiviral drug Entecavir (E558900).
2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate 준비 용품 및 원자재
원자재
준비 용품
2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate 공급 업체
글로벌( 69)공급 업체
China 63
India 4
United States 2
Global 69
2-amino-9-((1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one hydrate 관련 검색:
Entecavir Impurity
Entecavir hydrate
Entecavir
(1S,3S,4R)-Entecavir
(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol
(1R,3R,4R)-Entecavir
2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one
Entecavir Impurity 17(Entecavir EP Impurity C)
6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine
6-O-Benzyl-4-dehydroxy-4-diMethylphenylsilyl Entecavir
(1'S,3'S,4'S)-Entecavir IsoMer
2-AMino-1,9-dihydro-9-[(1S,3R,4S)-4-(hydroxydiMethylsilyl)-3-(hydroxyMethyl)-2-Methylenecyclopentyl]-6H-purin-6-one
(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol
(1S, 2R)-2-(Benzyloxymethyl)-1-hydroxy-3-cyclopentene
Entecavir Impurity 5
(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(benzyloxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanone
Entecavir Impurity 6
2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one
